Northern Trust’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.59M | Buy |
318,943
+217,817
| +215% | +$2.45M | ﹤0.01% | 2660 |
|
2025
Q1 | $576K | Buy |
101,126
+6,250
| +7% | +$35.6K | ﹤0.01% | 3517 |
|
2024
Q4 | $932K | Buy |
94,876
+9,791
| +12% | +$96.1K | ﹤0.01% | 3427 |
|
2024
Q3 | $693K | Sell |
85,085
-62,597
| -42% | -$510K | ﹤0.01% | 3477 |
|
2024
Q2 | $1.97M | Sell |
147,682
-1,483
| -1% | -$19.8K | ﹤0.01% | 2904 |
|
2024
Q1 | $6.92M | Sell |
149,165
-4,477
| -3% | -$208K | ﹤0.01% | 2279 |
|
2023
Q4 | $10.4M | Buy |
153,642
+4,892
| +3% | +$331K | ﹤0.01% | 2043 |
|
2023
Q3 | $10.8M | Buy |
148,750
+14,716
| +11% | +$1.07M | ﹤0.01% | 1952 |
|
2023
Q2 | $9.97M | Buy |
134,034
+23,728
| +22% | +$1.77M | ﹤0.01% | 2067 |
|
2023
Q1 | $5.87M | Buy |
110,306
+7,868
| +8% | +$419K | ﹤0.01% | 2358 |
|
2022
Q4 | $6.92M | Buy |
102,438
+25,088
| +32% | +$1.7M | ﹤0.01% | 2255 |
|
2022
Q3 | $9.65M | Sell |
77,350
-5,831
| -7% | -$728K | ﹤0.01% | 1992 |
|
2022
Q2 | $7.92M | Buy |
83,181
+33,257
| +67% | +$3.17M | ﹤0.01% | 2202 |
|
2022
Q1 | $8.05M | Sell |
49,924
-1,370
| -3% | -$221K | ﹤0.01% | 2285 |
|
2021
Q4 | $17.1M | Buy |
+51,294
| New | +$17.1M | ﹤0.01% | 1890 |
|